Nuclera, a biotechnology company enabling rapid protein expression and purification screening through its benchtop protein platform, has appointed William J Kullback as a non-executive director.
TechnologyAlcidion: Will Smart

Alcidion, which provides the Electronic Patient Record (EPR) platform Miya Precision, has appointed Will Smart as a non-executive director.
A former national chief information officer for health and social care in England, Smart joins the Alcidion Group board in a global role from next month, providing strategic insight as the company promotes its digital front line services in different parts of the world.
During an extensive career in digital health, Smart has advised senior government ministers, has played leading roles in initiatives including the Global Digital Exemplar programme, and has helped to drive technology adoption from within the health technology industry.
He is a former global director of external relations for Dedalus Group and has also held executive roles at several NHS trusts, including group chief information officer for the Royal Free London NHS Foundation Trust.
He is a digital non-executive director for Great Western Hospitals NHS Foundation Trust, and is a member of the Acute Hospitals Alliance EPR Joint Committee, which is responsible for overseeing the delivery of a shared EPR across three NHS trusts.
Smart is a director of CareTech Partners, which provides digital advisory and consultancy support. He is also a member of Health and Social Care Council at techUK, a trade association which represents and champions companies in the UK technology sector.
Smart said: “Alcidion continues to win really interesting projects, as healthcare systems work to advance digitisation. The company deserves mindshare from healthcare CIOs for its very impressive modern, interoperable, standards-based EPR platform, and for technologies now needed to address key issues such as how patients flow across systems. I look forward to sharing ideas and working closely with the Alcidion team, who have proven themselves to be thoughtful and committed in delivering the best possible products and outcomes for customers.”
Alcidion’s chief executive Kate Quirke commented: “Will’s extensive experience in digitising front line services will help to inform our strategic direction as we continue to serve more and more healthcare providers throughout the world, with genuine solutions to meet their needs. We look forward to inspiring and open discussions that will help to further enhance our effectiveness in this mission.”
Latest Executive Moves
Cambridge Cognition, which provides cognitive assessment software for clinical trials, academic research and healthcare, has appointed Jonathan Kempster as an independent non-executive director.
TechnologyStax has appointed Adam Thorpe as a managing director in its London office to lead the firm’s EMEA healthcare vertical.